Clinically Relevant Drug-Drug Interactions and Management Strategies: A Hospital based Study
Abstract
Background: Drug-drug interactions (DDIs) are one of the significant drug related problems encountered in clinical settings. Better understanding of the mechanisms, severity, and likely consequences of clinically significant DDIs are essential for proper medication therapy management (MTM). This study is conducted with the aim to aware clinical practitioners about clinically significant DDIs that occur in clinical settings and to help them manage such events with the accurate knowledge and technique.
Methods: A descriptive cross-sectional study was conducted in Shree Birendra Hospital, Kathmandu on the prescription of medical out-patient department from June to November 2020. Total 483 prescriptions were selected randomly. A panel of physicians, pharmacologists and clinical pharmacists under the supervision of a consultant physician using MICROMEDEX DRUG-REAX, Evaluation of Drug Interactions, Drug Interaction Facts, Drug Interactions: Analysis and Management was conducted. Main outcome measure was obtained by the supervisor’s endorsement on panelists' opinion about clinical importance of DDIs.
Results: A total of 2006 medicines were prescribed in 483 prescription samples. The number of drugs per prescription was in a range from 2 to 11 with 4.15 on average. DDIs were found in 21.53% prescriptions (n=104). 168 DDIs were identified with major, moderate, and minor types in 32 (19%), 85 (51%), and 51 (30%) respectively. As per occurrence, the panel determined that 13 interactions were clinically important.
Conclusion: The drug interactions identified by a panel of expert using standard evaluation tool are considered to be clinically important and likely to occur in the clinical settings. Clinically significant DDIs can be preventable and can also be used for the beneficial effects in MTM. Adequate knowledge regarding nature of DDIs, inclusion of automated system in prescribing and dispensing area, and inter-professional collaboration of a clinical team is liable to prevent and manage such events and help in rational drug therapy.
References
World Health Organizations. The Pursuit of Responsible Use of Medicines: Sharing and Learning from Country Experiences. World Health Organizations; 2012. [Google Scholar]
Takarabe M, Shigemizu D, Kotera M, Goto S, Kanehisa M. Network-based analysis and characterization of adverse drug-drug interactions. J Chem Inf Model. 2011 Nov;51(11):2977–85. https://doi.org/10.1021/ci200367w [Google Scholar] [PubMed]
Alhouzani T, Saleem M, Khadka S, Al-Subari S, Shrestha D, Butt I. Toxicity Profiles of Commonly Used Anti-Inflammatory Drugs in Geriatrics. Eur J Med Sci. 2020;2(2). https://doi.org/10.46405/ejms.v2i2.107 [Google Scholar]
Köhler GI, Bode-Böger SM, Busse R, Hoopmann M, Welte T, Böger RH. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther. 2000 Nov;38(11):504–13. https://doi.org/10.5414/CPP38504 [Google Scholar] [PubMed]
Zhang L, Zhang YD, Zhao P, Huang S-M. Predicting drug-drug interactions: an FDA perspective. AAPS J. 2009 Jun;11(2):300–6. https://doi.org/10.1208/s12248-009-9106-3 [Google Scholar] [PubMed]
Juurlink D, Mamdani M, Kopp A, Laupacis A, Redelmeier D. Drug-drug interactions among elderly patients hospitalized for drug toxicity. Jama. 2003;289(13):1652–8. https://doi.org/10.1001/jama.289.13.1652 [Google Scholar] [PubMed]
van Roon EN, Flikweert S, le Comte M, Langendijk PNJ, Kwee-Zuiderwijk WJM, Smits P, et al. Clinical relevance of drug-drug interactions : a structured assessment procedure. Drug Saf. 2005;28(12):1131–9. https://doi.org/10.2165/00002018-200528120-00007 [Google Scholar] [PubMed]
Aparasu R, Baer R, Aparasu A. Clinically important potential drug-drug interactions in outpatient settings. Res Social Adm Pharm. 2007 Dec;3(4):426–37. https://doi.org/10.1016/j.sapharm.2006.12.002 [Google Scholar] [PubMed]
Evaluations of drug interactions. First DataBank, St. Louis, Mo. The Hearst Corporation; 2001.
Drug interaction facts. St. Louis, Mo.: Facts and Comparisons; 2001.
Drug interactions: analysis and management. St. Louis, Mo.: Facts and Comparisons; 2001.
DRUG-REAX system. Micromedex, Greenwood Village, Colo; 2001.
Malone D, Armstrong E, Abarca J, Grizzle A, Hansten P, Van Bergen R, et al. Identification of serious drug–drug interactions: results of the partnership to prevent drug–drug interactions. J Am Pharm Assoc. 2004;44(2):142–51. https://doi.org/10.1331/154434504773062591 [Google Scholar] [PubMed]
Shrestha R, Prajapati S. Assessment of prescription pattern and prescription error in outpatient Department at Tertiary Care District Hospital, Central Nepal. J Pharm policy Pract. 2019;12:16. https://doi.org/10.1186/s40545-019-0177-y [Google Scholar] [PubMed]
Kothari N, Ganguly B. Potential Drug - Drug Interactions among Medications Prescribed to Hypertensive Patients. J Clin Diagn Res. 2014 Nov;8(11):HC01-4. https://doi.org/10.7860/JCDR/2014/10032.5091 [Google Scholar] [PubMed]
Malone D, Abarca J, Hansten P, Grizzle A, Armstrong E, Van Bergen R, et al. Identification of serious drug-drug interactions: Results of the partnership to prevent drug-drug interactions. Am J Geriatr Pharmacother. 2005;3(2):65–76. https://doi.org/10.1016/j.amjopharm.2005.05.001 [Google Scholar] [PubMed]
Egger SS, Drewe J, Schlienger RG. Potential drug-drug interactions in the medication of medical patients at hospital discharge. Eur J Clin Pharmacol. 2003 Mar;58(11):773–8. https://doi.org/10.1007/s00228-002-0557-z [Google Scholar] [PubMed]
MECHANIC D. Rethinking Medical Professionalism: The Role of Information Technology and Practice Innovations. Milbank Q [Internet]. 2008;86(2):327–58. https://doi.org/10.1111/j.1468-0009.2008.00523.x [Google Scholar] [PubMed]
Manasse Jr H. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 2. Am J Heal Pharm. 1989;46(6):1141–52. https://doi.org/10.1093/ajhp/46.6.1141 [Google Scholar] [PubMed]
Manasse Jr H. Medication use in an imperfect world: drug misadventuring as an issue of public policy, part 1. Am J Heal Pharm. 1989;46(5):929–44. https://doi.org/10.1093/ajhp/46.5.929 [Google Scholar] [PubMed]
Soumerai SB, Lipton HL. Computer-based drug-utilization review--risk, benefit, or boondoggle? N Engl J Med. 1995 Jun;332(24):1641–5. https://doi.org/10.1056/NEJM199506153322411 [Google Scholar] [PubMed]
Crane J, Crane FG. Preventing Medication Errors in Hospitals through a Systems Approach and Technological Innovation: A Prescription for 2010. Hosp Top [Internet]. 2006;84(4):3–8. https://doi.org/10.3200/HTPS.84.4.3-8 [Google Scholar] [PubMed]
Armstrong EP, Chrischilles EA. Electronic Prescribing and Monitoring Are Needed to Improve Drug Use. Arch Intern Med. 2000;160(18):2713–4. https://doi.org/10.1001/archinte.160.18.2713 [Google Scholar] [PubMed]
Prescott LF. Clinically important drug interactions. Drugs. 1973;5(3):161–86. https://doi.org/10.2165/00003495-197305030-00001 [Google Scholar] [PubMed]
Raval D, Saraswathy N, Meghani N, Shah H. Contribution of drug interactions to burden of preventable ADR’S: Approches to predict and prevent drug interactions. Indian J Pharm Pract. 2011;4(1). [Google Scholar]
Murphy JE, Malone DC, Olson BM, Grizzle AJ, Armstrong EP, Skrepnek GH. Development of computerized alerts with management strategies for 25 serious drug–drug interactions. Am J Heal Pharm. 2009;66(1):38–44. https://doi.org/10.2146/ajhp070046 [Google Scholar] [PubMed]
Copyright (c) 2020 Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles published in EJMS are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). The author(s) as the copyright holder will retain the ownership of the copyrights without any restrictions for their content under the CC-BY 4.0 license, and allow others to copy, use, print, share, modify, and distribute the content of the article even in commercial purpose as long as the original authors and the journal are properly cited. No permission is required from the author/s or the publishers. Appropriate attribution can be provided by simply citing the original article.
On behalf of all the authors, the corresponding author is responsible for completing and returning the agreement form to the editorial office. More information about the terms and conditions, privacy policies, and copyrights can be found on the webpage of the Creative Commons license privacy policy. https://creativecommons.org/licenses/by/4.0/
